Abstract
This study examined (a) demographic and clinical characteristics associated with physical symptoms in anxiety-disordered youth and (b) the impact of cognitive-behavioral therapy (Coping Cat), medication (sertraline), their combination, and pill placebo on physical symptoms. Youth (N = 488, ages 7–17 years) with a principal diagnosis of generalized anxiety disorder, separation anxiety disorder, or social phobia participated as part of a multi-site, randomized controlled trial and received treatment delivered over 12 weeks. Diagnostic status, symptom severity, and impairment were assessed at baseline and week 12. The total number and severity of physical symptoms was associated with age, principal diagnosis, anxiety severity, impairment, and the presence of comorbid internalizing disorders. Common somatic complaints were headaches, stomachaches, head cold or sniffles, sleeplessness, and feeling drowsy or too sleepy. Physical symptoms decreased over the course of treatment, and were unrelated to treatment condition. Clinical implications and directions for future research are discussed (ClinicalTrials.gov number, NCT00052078).
Similar content being viewed by others
Notes
Youth with comorbid, secondary depression were initially included in CAMS. However a decision was made to exclude youth with major depressive disorder (MDD) early in the trial. Participants with comorbid, secondary dysthymia were included throughout the trial.
Site differences in demographic variables have been discussed by Walkup et al. [20].
Findings did not differ when analyses were conducted using the intent-to-treat sample with last observation carried forward versus participants with complete data at baseline and week 12.
References
Costello EJ, Mustillo S, Erkanli A, Keeler G, Angold A (2003) Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 60(8):837–844
Ezpeleta L, Keeler G, Erkanli A, Costello EJ, Angold A (2001) Epidemiology of psychiatric disability in childhood and adolescence. J Child Psychol Psychiatry 42(7):901–914
Van Ameringen M, Mancini C, Farvolden P (2003) The impact of anxiety disorders on educational achievement. J Anxiety Disord 17(5):561–571
Bittner A, Egger HL, Erkanli A, Jane costello E, Foley DL, Angold A (2007) What do childhood anxiety disorders predict? J Child Psychol Psychiatry 48(12):1174–1183
Costello EJ, Angold A (eds) (1995) Epidemiology. Guilford, New York
Ferdinand RF, Verhurlst FC (1995) Psychopathology from adolescence into young adulthood: an 8-year follow-up study. Am J Psychiatry 152:1586–1594
Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, Merikangas KR et al (2010) Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey. Addiction 105(6):1117–1128
Woodward LJ, Fergusson DM (2001) Life course outcomes of young people with anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry 40(9):1086–1093
Beidel DC, Christ MAG, Long PJ (1991) Somatic complaints in anxious children. J Abnorm Child Psychol 19:659–670
Ginsburg GS, Riddle MA, Davies M (2006) Somatic symptoms in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 45(10):1179–1187
Hofflich SA, Hughes AA, Kendall PC (2006) Somatic complaints and childhood anxiety disorders. Int J Clin Health Psychol 6:229–242
American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders: DSM-IV-TR (4th ed.). Author, Washington
Garber J, Walker LS, Zeman J (1991) Somatization symptoms in a community sample of children and adolescents: further validation of the Children’s Somatization Inventory. Psychol Assess 3(4):588–595
Kingery JN, Ginsburg GS, Alfano CA (2007) Somatic symptoms and anxiety among African American adolescents. J Black Psychol 33(4):363–378
Last CG (1991) Somatic complaints in anxiety disordered children. J Anxiety Disord 5(2):125–138
Storch EA, Merlo LJ, Keeley ML, Grabill K, Milsom VA, Geffken GR et al (2008) Somatic symptoms in children and adolescents with obsessive-compulsive disorder: associations with clinical characteristics and cognitive-behavioral therapy response. Behav Cogn Psychother 36(03):283–297
Hughes AA, Lourea-Waddell B, Kendall PC (2008) Somatic complaints in children with anxiety disorders and their unique prediction of poorer academic performance. Child Psychiatry Hum Dev 39(2):211–220
Bernstein GA, Massie ED, Thuras PD, Perwien AR, Borchardt CM, Crosby RD (1997) Somatic symptoms in anxious-depressed school refusers. J Am Acad Child Adolesc Psychiatry 36(5):661–668
Masia-Warner C, Colognori D, Kim RE, Reigada LC, Klein RG, Browner-Elhanan KJ et al (2011) Cognitive-behavioral treatment of persistent functional somatic complaints and pediatric anxiety: an initial controlled trial. Depress Anxiety 28(7):551–559
Walkup JT, Albano AM, Piacentini J, Birmaher B, Compton SN, Sherrill JT et al (2008) Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med 359(26):2753–2766
Silverman WK, Albano AM (1996) The anxiety disorders interview schedule for DSM-IV-child and parent versions. Graywind Publications, San Antonio
Compton SN, Walkup JT, Albano AM, et al. Child/adolescent anxiety multimodal study (CAMS): rationale, design, and methods. Child Adolesc Psychiatry Ment Health 4(1): 1–15
Hollingshead AB (1975). Four factor index of social status. Unpublished manuscript. Department of Sociology, Yale University
Kendall PC, Compton SN, Walkup JT, Birmaher B, Albano AM, Sherrill J et al (2010) Clinical characteristics of anxiety disordered youth. J Anxiety Disord 24(3):360–365
Silverman WK, Nelles WB (1988) The anxiety disorders interview schedule for children. J Am Acad Child Adolesc Psychiatry 27(6):772–778
Silverman WK, Eisen AR (1992) Age differences in the reliability of parent and child reports of child anxious symptomatology using a structured interview. J Am Acad Child Adolesc Psychiatry 31(1):117–124
Emslie G, Kratochvil C, Vitiello B, Silva S, Mayes T, McNulty S et al (2006) Treatment for adolescents with depression study (TADS): safety results. J Am Acad Child Adolesc Psychiatry 45(12):1440–1455
Research Units on Pediatric Psychopharmacology Anxiety Study (2002) The pediatric anxiety rating scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 41:1061–1069
Ginsburg GS, Keeton CP, Drazdowski TK, Riddle MA (2011) The utility of clinicians ratings of anxiety using the pediatric anxiety rating scale (PARS). Child Youth Care Forum 40(2):93–105
Shaffer D (1983) A children’s global assessment scale (CGAS). Arch Gen Psychiatry 40(11):1228–1231
Bird HR (1987) Further measures of the psychometric properties of the children’s global assessment scale. Arch Gen Psychiatry 44(9):821–824
Guy W (1976) ECDEU assessment manual for psychopharmacology, revised. National Institute of Mental Health, Rockville
Kendall PC, Hedtke K (2006) Cognitive-behavioral therapy for anxious children: therapist manual (3rd ed). Workbook Publishing, Ardmore
Kendall PC, Hedtke K (2006) Coping cat workbook (2nd ed.). Workbook Publishing, Ardmore
Kendall PC, Choudhury M, Hudson J, Webb A (2002) The C.A.T project workbook for the cognitive-behavioral treatment of anxious adolescents. Workbook Publishing, Ardmore
Podell JL, Kendall PC, Gosch EA, Compton SN, March JS, Albano AM, Piacentini JC (2013) Therapist factors and outcomes in CBT for anxiety in youth. Prof Psychol Res Pract 44(2):89
Safer DJ, Zito JM (2006) Treatment-emergent adverse effects from selective serotonin reuptake inhibitors by age group: children versus adolescents. J Child Adolesc Psychopharmacol 16:159–169
Ialongo N, Edelsohn G, Werthamer-Larsson L, Crockett L, Kellam S (1995) The significance of self-reported anxious symptoms in first grade children: prediction to anxious symptoms and adaptive functioning in fifth grade. J Child Psychol Psychiatry 36(3):427–437
Strauss CC, Frame CL, Forehand R (1987) Psychosocial impairment associated with anxiety in children. J Clin Child Psychol 16(3):235–239
Acknowledgments
This research was supported by grants (U01 MH064089, to Dr. Walkup; U01 MH64092, to Dr. Albano; U01 MH64003, to Dr. Birmaher; U01 MH63747, to Dr. Kendall, U01 MH64107, to Dr. March; U01 MH64088, to Dr. Piacentini; and U01 MH064003, to Dr. Compton) from the National Institute of Mental Health. Sertraline and matching placebo were supplied free of charge by Pfizer. Views expressed within this article represent those of the authors and are not intended to represent the position of NIMH, NIH, or DHHS.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Crawley, S.A., Caporino, N.E., Birmaher, B. et al. Somatic Complaints in Anxious Youth. Child Psychiatry Hum Dev 45, 398–407 (2014). https://doi.org/10.1007/s10578-013-0410-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10578-013-0410-x